Compare Stocks → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AFIBNASDAQ:ICUNASDAQ:NMRDNASDAQ:NMTC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.17$0.19$0.16▼$1.09$4.98M0.191.94 million shs354,569 shsICUSeaStar Medical$0.44+7.4%$0.80$0.16▼$2.28$22.33M-1.182.23 million shs2.64 million shsNMRDNemaura Medical$0.07-12.2%$0.08$0.07▼$1.25$3.39M-0.0610,956 shs42,662 shsNMTCNeuroOne Medical Technologies$1.14-0.9%$1.17$0.85▼$2.00$29.82M0.81296,835 shs72,192 shsThe Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical-1.41%-1.93%-9.41%-1.41%-78.76%ICUSeaStar Medical+7.60%-34.23%-45.40%-45.72%-79.44%NMRDNemaura Medical-14.34%-3.36%-15.11%-25.39%-91.82%NMTCNeuroOne Medical Technologies-0.87%+1.79%-3.39%-15.56%-28.30%The "Smart Money" Is Ready for May 1st Are You? (Ad)Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAFIBAcutus MedicalN/AN/AN/AN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/AN/AN/AN/ANMRDNemaura Medical1.744 of 5 stars3.50.00.04.50.61.70.0NMTCNeuroOne Medical Technologies0.8121 of 5 stars3.53.00.00.00.60.00.0Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFIBAcutus MedicalN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/ANMRDNemaura Medical3.00Buy$2.503,372.22% UpsideNMTCNeuroOne Medical Technologies3.00Buy$2.2092.98% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFIBAcutus Medical$7.16M0.70N/AN/A($0.03) per share-5.59ICUSeaStar MedicalN/AN/AN/AN/A($0.25) per shareN/ANMRDNemaura Medical$80K36.32N/AN/A($0.41) per share-0.18NMTCNeuroOne Medical Technologies$1.95M15.16N/AN/A$0.26 per share4.38Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFIBAcutus Medical-$81.66M-$1.24N/A∞N/A-166.79%-35.31%-13.43%5/9/2024 (Estimated)ICUSeaStar Medical-$26.23M-$1.21N/A∞N/AN/AN/A-741.57%5/20/2024 (Estimated)NMRDNemaura Medical-$14.14M-$0.39N/A∞N/AN/AN/A-142.69%N/ANMTCNeuroOne Medical Technologies-$11.86M-$0.68N/A∞N/A-478.41%-267.82%-200.46%5/9/2024 (Estimated)Latest NMRD, AFIB, ICU, and NMTC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/13/2024Q1 2024NMTCNeuroOne Medical TechnologiesN/A-$0.14-$0.14-$0.14N/A$0.98 million 2/12/2024Q3 2024NMRDNemaura MedicalN/A-$0.12-$0.12-$0.17N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAFIBAcutus MedicalN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/ANMRDNemaura MedicalN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFIBAcutus Medical1.102.442.22ICUSeaStar MedicalN/A0.180.18NMRDNemaura MedicalN/A0.190.03NMTCNeuroOne Medical TechnologiesN/A3.682.52OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFIBAcutus Medical56.91%ICUSeaStar Medical1.69%NMRDNemaura Medical4.41%NMTCNeuroOne Medical Technologies16.07%Insider OwnershipCompanyInsider OwnershipAFIBAcutus Medical3.50%ICUSeaStar Medical4.50%NMRDNemaura Medical41.60%NMTCNeuroOne Medical Technologies7.50%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAFIBAcutus Medical23029.72 million28.68 millionOptionableICUSeaStar Medical955.12 million52.64 millionNot OptionableNMRDNemaura Medical3640.35 million23.57 millionOptionableNMTCNeuroOne Medical Technologies1625.93 million23.99 millionOptionableNMRD, AFIB, ICU, and NMTC HeadlinesSourceHeadlineNeuroOne® Announces First Implant of OneRF(TM) Ablation Electrodesstockhouse.com - April 11 at 2:46 PMNeuroOne® CEO Dave Rosa Featured on Bloomberg Technologyglobenewswire.com - April 10 at 9:00 AMNeuroOne implants first OneRF ablation electrodemassdevice.com - April 9 at 2:44 PMNeuroOne® Announces First Implant of OneRF™ Ablation Electrodesglobenewswire.com - April 9 at 9:05 AMNeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.finance.yahoo.com - April 4 at 9:06 AMNeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co.globenewswire.com - April 4 at 9:00 AMNeuroOne® Initiates Limited Commercial Launch of OneRF(TM) Ablation Systemstockhouse.com - March 28 at 3:16 PMNeuroOne begins neuroablation system launch in U.S.massdevice.com - March 27 at 11:04 AMNeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation Systemfinance.yahoo.com - March 26 at 10:19 AMNeuroone Medical Technologies Corp (NMTC)investing.com - March 22 at 11:04 PMNMTC Jul 2024 2.500 callca.finance.yahoo.com - March 17 at 8:55 PMNeuroOne® to Participate in the 36th Annual Roth Conferenceglobenewswire.com - March 8 at 12:00 PMNeuroOne Medical Technologies Corp: NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - February 24 at 8:52 AMNeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - February 23 at 5:10 PMNeuroOne Medical Technologies Corp: NeuroOne Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Updatefinanznachrichten.de - February 16 at 11:11 AMNeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - February 16 at 11:11 AMNeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcriptseekingalpha.com - February 16 at 12:01 AMNeuroOne Medical Technologies Corporation Registered Shsmarkets.businessinsider.com - February 15 at 7:00 PMNeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Linefinance.yahoo.com - February 15 at 9:00 AMNeuroOne Medical Technologies GAAP EPS of -$0.14msn.com - February 13 at 5:02 PMNeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Updatefinance.yahoo.com - February 13 at 5:02 PMNeuroOne Medical Technologies earnings: here's what Wall Street expectsmarkets.businessinsider.com - February 12 at 3:57 PMNeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13finance.yahoo.com - February 8 at 3:55 PMNeuroOne Medical Technologies Corp.wsj.com - January 24 at 1:05 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to Come3 High Dividend Stocks to Replace Lower Savings Yields AheadApril 9, 2024 9:15 AMView 3 High Dividend Stocks to Replace Lower Savings Yields AheadPredicting a Bear Market: 7 Signs and Why it's Tough to DoApril 17, 2024 12:00 PMView Predicting a Bear Market: 7 Signs and Why it's Tough to DoAll Headlines Company DescriptionsAcutus MedicalNASDAQ:AFIBAcutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.SeaStar MedicalNASDAQ:ICUSeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.Nemaura MedicalNASDAQ:NMRDNemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.NeuroOne Medical TechnologiesNASDAQ:NMTCNeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.